CD34 and acute myeloid leukemia: Transplantation of high doses of immune-selected CD34+ cells collected from haploidentical donors after myelo-ablative conditioning regimen has provided a setting which demonstrates that “KIR-incompatibility” was associated with lower incidence of disease relapses, at least for AML (19).